Latest news

Bioservo Technologies AB Interim Report January – March 2022 (regulatory information)

Bioservo is investing further in Life Science

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

Shareholders

The biggest shareholders 2022-03-31

Namn Percent (%) Shares
Tellacq Group AB 17,34% 3 288 000
Anders Lundmark 8,18% 1 551 021
Försäkringsaktiebolaget, Avanza Pension 6,99% 1 325 287
Adrigo Small & Midcap L/S 5,82% 1 103 633
Tomas Ward + Ward Invest 3,49% 661 524
Danske Bank International S.A, Luxemburg 2,87% 544 000
Nordnet Pensionsförsäkring AB 2,44% 463 313
Magnus Lundberg 2,36% 447 625
Simon Josefsson Datakonsult AB 2,25% 427 330
Jens Christian Miöen 1,97% 374 353
Other 46,29% 8 771 869
Total 100,00% 18 957 985